tiprankstipranks
Advertisement
Advertisement

DE:JNJ Stock Latest News

Protagonist Therapeutics announces $300M share repurchase program
The FlyProtagonist Therapeutics announces $300M share repurchase program
1d ago
JNJ
TAK
Johnson & Johnson assumed with a Buy at UBS
PremiumThe Fly
Johnson & Johnson assumed with a Buy at UBS
7d ago
JNJ
Stellantis appoints Stephanie Hartgrove chief communications officer
PremiumThe Fly
Stellantis appoints Stephanie Hartgrove chief communications officer
9d ago
JNJ
STLA
FDA approves Imaavy for warm autoimmune hemolytic anemia
PremiumThe Fly
FDA approves Imaavy for warm autoimmune hemolytic anemia
15d ago
JNJ
FDA approves J&J’s Imaavy for treatment of warm autoimmune hemolytic anemia
PremiumThe Fly
FDA approves J&J’s Imaavy for treatment of warm autoimmune hemolytic anemia
16d ago
JNJ
Protagonist Therapeutics price target raised to $178 from $112 at BMO Capital
PremiumThe FlyProtagonist Therapeutics price target raised to $178 from $112 at BMO Capital
23d ago
JNJ
PTGX
Oppenheimer upgrades Intuitive Surgical on lack of U.S. competition
Premium
The Fly
Oppenheimer upgrades Intuitive Surgical on lack of U.S. competition
23d ago
JNJ
ISRG
Oppenheimer downgrades Legend Biotech to Perform on CEO/competition overhangs
Premium
The Fly
Oppenheimer downgrades Legend Biotech to Perform on CEO/competition overhangs
23d ago
JNJ
LEGN
Trump Trade: President signs EO to split up of childhood vaccines
PremiumThe Fly
Trump Trade: President signs EO to split up of childhood vaccines
29d ago
AZN
EBS
Trump signs EO to split up of childhood vaccines, Bloomberg reports
PremiumThe Fly
Trump signs EO to split up of childhood vaccines, Bloomberg reports
1M ago
AZN
EBS
Protagonist Therapeutics price target raised to $173 from $118 at Wedbush
PremiumThe Fly
Protagonist Therapeutics price target raised to $173 from $118 at Wedbush
1M ago
JNJ
PTGX
Trump Trade: U.S. issues 15% duty on products made from polysilicon
PremiumThe Fly
Trump Trade: U.S. issues 15% duty on products made from polysilicon
1M ago
AZN
EBS
Trump admin plans to issue executive order on vaccines, autism, Bloomberg says
PremiumThe FlyTrump admin plans to issue executive order on vaccines, autism, Bloomberg says
1M ago
AZN
EBS
Johnson & Johnson price target raised to $287 from $270 at Guggenheim
Premium
The Fly
Johnson & Johnson price target raised to $287 from $270 at Guggenheim
1M ago
JNJ
Zymeworks price target raised to $51 from $46 at H.C. Wainwright
Premium
The Fly
Zymeworks price target raised to $51 from $46 at H.C. Wainwright
1M ago
JNJ
JAZZ
JNJ’s OTTAVA Robotics and Medtech Strategy Underpin Buy Rating and Unchanged $282 Price Target
PremiumRatings
JNJ’s OTTAVA Robotics and Medtech Strategy Underpin Buy Rating and Unchanged $282 Price Target
1M ago
JNJ
Ottava Robotic Platform and MedTech Upside Underscore Buy Rating on JNJ with Unchanged $294 Price Target
PremiumRatings
Ottava Robotic Platform and MedTech Upside Underscore Buy Rating on JNJ with Unchanged $294 Price Target
1M ago
JNJ
Johnson & Johnson announces leadership change in Innovative Medicine
PremiumCompany Announcements
Johnson & Johnson announces leadership change in Innovative Medicine
1M ago
8K
JNJ
Johnson & Johnson announces Taubert to retire as EVP, Worldwide Chairman
PremiumThe Fly
Johnson & Johnson announces Taubert to retire as EVP, Worldwide Chairman
1M ago
JNJ
Johnson & Johnson price target raised to $282 from $272 at Wells Fargo
PremiumThe FlyJohnson & Johnson price target raised to $282 from $272 at Wells Fargo
1M ago
JNJ
Johnson & Johnson removed from US Conviction List at Goldman Sachs
Premium
The Fly
Johnson & Johnson removed from US Conviction List at Goldman Sachs
1M ago
JNJ
Johnson & Johnson’s head & neck cancer candidate granted FDA Priority Review
Premium
The Fly
Johnson & Johnson’s head & neck cancer candidate granted FDA Priority Review
1M ago
JNJ

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >